Zhu X - Search Results

1

Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy.

Gu J, Liu S, Cui W, Dai H, Cui Q, Yin J, Li Z, Kang L, Qiu H, Han Y, Miao M, Chen S, Xue S, Wang Y, Jin Z, Zhu X, Yu L, Wu D, Tang X. Gu J, et al. Among authors: zhu x. Front Immunol. 2022 Mar 17;13:858590. doi: 10.3389/fimmu.2022.858590. eCollection 2022. Front Immunol. 2022. PMID: 35371098 Free PMC article.

2

[Pulmonary disease caused by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation--a case report and literature review].

Chen B, Wu DP, Sun AN, Qiu HY, Fu ZZ, Tang XW, Ma X, Jin ZM, Miao M, He GS, Liu YJ, Zhao Y, Wu XJ, Zhu XM. Chen B, et al. Among authors: zhu xm. Zhonghua Xue Ye Xue Za Zhi. 2004 Aug;25(8):470-2. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15555262 Chinese.

3

[Efficacy and safety study of subcutaneous injection of bortezomib in the treatment of de novo patients with multiple myeloma].

Liu H, Fu CC, Xue SL, Li WY, Wu Q, Gu B, Jin S, Zhu XM, Zhao SF, Xin X, Ma L, Sun AN, Wu DP. Liu H, et al. Among authors: zhu xm. Zhonghua Xue Ye Xue Za Zhi. 2013 Oct;34(10):868-72. doi: 10.3760/cma.j.issn.0253-2727.2013.10.009. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 24171961 Clinical Trial. Chinese.

4

Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.

Ge L, Ye F, Mao X, Chen J, Sun A, Zhu X, Qiu H, Jin Z, Miao M, Fu C, Ma X, Chen F, Xue S, Ruan C, Wu D, Tang X. Ge L, et al. Among authors: zhu x. Biol Blood Marrow Transplant. 2014 Jul;20(7):1040-7. doi: 10.1016/j.bbmt.2014.03.030. Epub 2014 Apr 2. Biol Blood Marrow Transplant. 2014. PMID: 24704575 Free article.

5

Successful Treatment of Relapsed Acute Myeloid Leukemia Without Chemotherapy.

Tang X, Song YH, Sun A, Zhu X, Ruan C, Wu D. Tang X, et al. Among authors: zhu x. J Clin Oncol. 2016 May 1;34(13):e117-9. doi: 10.1200/JCO.2012.48.0442. Epub 2014 Apr 7. J Clin Oncol. 2016. PMID: 24711555 No abstract available.

6

FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation.

Tang S, Shen H, Mao X, Dai H, Zhu X, Xue S, Ding Z, Lu J, Wu D, Tang X. Tang S, et al. Among authors: zhu x. Int J Hematol. 2017 Oct;106(4):552-561. doi: 10.1007/s12185-017-2256-7. Epub 2017 Jun 14. Int J Hematol. 2017. PMID: 28616699

7

Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.

Tang S, Shen H, Qu C, Dai H, Zhu X, Xue S, Ding Z, Lu J, Wu D, Tang X. Tang S, et al. Among authors: zhu x. Bone Marrow Transplant. 2019 Feb;54(2):236-243. doi: 10.1038/s41409-018-0249-7. Epub 2018 Jun 25. Bone Marrow Transplant. 2019. PMID: 29942002

8

Effects of preemptive interferon-α monotherapy in acute leukemia patients with relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study.

Lin XJ, Dai HP, Wang AJ, Chen F, Ma X, Sun AN, Zhu XM, Qiu HY, Jin ZM, Miao M, Xue SL, Mao XL, Wu DP, Tang XW. Lin XJ, et al. Among authors: zhu xm. Ann Hematol. 2018 Nov;97(11):2195-2204. doi: 10.1007/s00277-018-3429-z. Epub 2018 Jul 11. Ann Hematol. 2018. PMID: 29995264

9

First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.

Tang X, Yang L, Li Z, Nalin AP, Dai H, Xu T, Yin J, You F, Zhu M, Shen W, Chen G, Zhu X, Wu D, Yu J. Tang X, et al. Among authors: zhu x, zhu m. Am J Cancer Res. 2018 Jun 1;8(6):1083-1089. eCollection 2018. Am J Cancer Res. 2018. PMID: 30034945 Free PMC article.

10

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.

Tang C, Chen F, Kong D, Ma Q, Dai H, Yin J, Li Z, Chen J, Zhu X, Mao X, Wu D, Tang X. Tang C, et al. Among authors: zhu x. J Hematol Oncol. 2018 Aug 16;11(1):103. doi: 10.1186/s13045-018-0649-6. J Hematol Oncol. 2018. PMID: 30115080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36,948 results

Search Page